Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer. - Wikidata - awgldk - TriplyDB

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.

http://www.wikidata.org/entity/Q34311116

about

Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalk Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models Role of c-Src activity in the regulation of gastric cancer cell migration Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction.Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.Combining multi-dimensional data to identify key genes and pathways in gastric cancer SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma.17β-estradiol inhibits mesenchymal stem cells-induced human AGS gastric cancer cell mobility via suppression of CCL5- Src/Cas/Paxillin signaling pathway.The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer.Potential of targeted drug delivery system for the treatment of bone metastasis.Emerging kinase inhibitors of the treatment of gastric cancer.Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery.Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms.Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.Fluorescent visualization of Src by using dasatinib-BODIPY Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue.Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells.Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis.

P2860

Q26765201-C767398C-3FF9-4D93-90F7-1E0C8ABBE17A Q28544422-8D70316C-71A5-46D6-8927-52CE05BC2A0C Q33793942-01BCA2CA-283B-41C4-A424-863EBDD67F07 Q33799673-71DF172C-BF8D-4897-A4CC-BD48FE085D39 Q33882864-172839A8-1AC4-4DCA-9676-482ED9F03085 Q36140620-3C2EABBE-FDCE-4BB1-806E-9F01CEA35EBE Q36398831-27660BB9-32D2-471D-B18A-09F5F3606491 Q37327588-DA3F2BCC-D701-4C86-81DC-2CFBBDB47773 Q37434253-4D2EC374-B2A7-4562-865B-F334BCB74719 Q37698928-2BEC6FA1-8C06-4D8F-8DF7-8476E0E40D42 Q38212708-4F5EEAC9-A6D9-473C-93A1-0FDC6C1D8033 Q38506084-F07801FF-744A-41A1-A84B-27F3733FC97D Q38582337-DC21F012-705C-4658-86CE-5511660F4068 Q38812867-6D6C087B-96FC-47E2-8B73-AB10348FB8F4 Q38989374-82C1B00E-D2AF-4ACF-B0C2-CD195D17814E Q38994926-892240F3-9806-4EA9-B96D-4294AA64B4F7 Q39168334-9F8C782B-F8BA-48E6-AF7F-778CF6464FBC Q42678959-B3204138-71F7-42A4-82BE-52D5F73BA262 Q42953216-22E77097-459D-483F-915B-94644FD6331E Q49800452-4A935539-AECE-44AE-AA60-3A48EC785E7D

P2860

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.

http://www.wikidata.org/entity/Q34311116

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Antitumor activity of saracati ...... utic agents in gastric cancer.

@ast

Antitumor activity of saracati ...... utic agents in gastric cancer.

@en

Antitumor activity of saracati ...... utic agents in gastric cancer.

@nl

type

label

Antitumor activity of saracati ...... utic agents in gastric cancer.

@ast

Antitumor activity of saracati ...... utic agents in gastric cancer.

@en

Antitumor activity of saracati ...... utic agents in gastric cancer.

@nl

prefLabel

Antitumor activity of saracati ...... utic agents in gastric cancer.

@ast

Antitumor activity of saracati ...... utic agents in gastric cancer.

@en

Antitumor activity of saracati ...... utic agents in gastric cancer.

@nl

P1433

Q34311116-2211D130-20E1-4CEC-AB52-1799DD078405

P1476

Q34311116-F8ACC2BD-7E4B-413F-850F-07B908CB5585

P2093

Q34311116-05609477-1FFC-454D-A5EB-844E7D6D103D

Q34311116-0723A9FB-DDEC-4D37-B462-2291CF37D8C8

Q34311116-0AE8C63C-B389-4ACA-BACA-AC7969865930

Q34311116-28D5D90D-939C-4360-BB8B-40BF189AB87E

Q34311116-307D73A7-D2AE-4AD3-8A91-D9FE292BCB29

Q34311116-6D055C12-707C-47DE-84A8-91EF2F9A1FF1

Q34311116-7D82861E-7A91-4D67-8EEC-1B999B40D9F4

Q34311116-837EDF45-12E2-43D8-818E-106C8529DC2B

Q34311116-877A5844-98D2-48E2-8A40-DD8DF9937564

Q34311116-C88FD376-FD3C-45A8-AD7B-F85CBC43444F

P304

Q34311116-04758A0E-90BC-49F5-8CF9-5AE6626B5C63

P31

Q34311116-2D92316E-ABCC-4B1B-A938-42F45F50B4F5

P356

Q34311116-99BFFD9D-933A-41AE-9305-E93A3A680A2B

P433

Q34311116-B3284552-EC62-42A4-88C6-B6E382634A71

P478

Q34311116-6784B50B-6C4B-4FA6-BE4C-82617E8DCD59

P577

Q34311116-A5C88D9B-D39E-42A3-A585-A97220756DFC

P698

Q34311116-E1A68698-6173-43DB-9202-A6265819FB7B

P921

Q34311116-4590A001-46A6-47D6-A159-10610135B665

Q34311116-4B92D3CD-AFA3-4E96-8A4B-C546DEAF03CE

P356

1535-7163.MCT-12-0109

P1433

Molecular Cancer Therapeutics

P1476

Antitumor activity of saracati ...... utic agents in gastric cancer.

@en

P2093

Ahrum Min

http://www.w3.org/2001/XMLSchema#string

Do-Youn Oh

http://www.w3.org/2001/XMLSchema#string

Hwang-Phill Kim

http://www.w3.org/2001/XMLSchema#string

Hyun-Jin Nam

http://www.w3.org/2001/XMLSchema#string

Paul Elvin

http://www.w3.org/2001/XMLSchema#string

Sae-Won Han

http://www.w3.org/2001/XMLSchema#string

Sang-Hyun Song

http://www.w3.org/2001/XMLSchema#string

Seock-Ah Im

http://www.w3.org/2001/XMLSchema#string

Tae-You Kim

http://www.w3.org/2001/XMLSchema#string

Young-Kwang Yoon

http://www.w3.org/2001/XMLSchema#string

P304

16-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-12-0109

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23144237

http://www.w3.org/2001/XMLSchema#string

P921